Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001999480-26-000012
Filing Date
2026-05-13
Accepted
2026-05-13 07:30:44
Documents
68
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alto-20260331.htm   iXBRL 10-Q 867280
2 EX-31.1 exhibit311-302certceo1q2026.htm EX-31.1 13485
3 EX-31.2 exhibit312-302certcfo1q2026.htm EX-31.2 13578
4 EX-32.1 exhibit321-906certceo1q2026.htm EX-32.1 8019
5 EX-32.2 exhibit322-906certcfo1q2026.htm EX-32.2 8082
11 alto-20260331_g1.jpg GRAPHIC 874790
  Complete submission text file 0001999480-26-000012.txt   7881976

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alto-20260331.xsd EX-101.SCH 46432
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alto-20260331_cal.xml EX-101.CAL 57912
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alto-20260331_def.xml EX-101.DEF 260808
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alto-20260331_lab.xml EX-101.LAB 628043
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alto-20260331_pre.xml EX-101.PRE 442049
74 EXTRACTED XBRL INSTANCE DOCUMENT alto-20260331_htm.xml XML 617435
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41944 | Film No.: 26970939
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)